Vincent Castonguay
- Oncology top 5%
- Obstetrics and Gynecology top 1%
- Epidemiology top 10%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Vanessa SamouëlianRonnie Shapira‐FrommerPamela SalmanMivael OliveraCoraline DubotKan LiKrishnansu S. TewariKosei Hasegawa
- Topics
- Renal cell carcinoma treatment (17 papers)Cancer Immunotherapy and Biomarkers (16 papers)Endometrial and Cervical Cancer Treatments (14 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesJournal of Clinical Oncology
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Vincent Castonguay
38 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 563
- Obstetrics and Gynecology 415
- Epidemiology 250
- Surgery 239
- Pulmonary and Respiratory Medicine 229
Countries citing papers authored by Vincent Castonguay
This map shows the geographic impact of Vincent Castonguay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Castonguay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Castonguay more than expected).
Fields of papers citing papers by Vincent Castonguay
This network shows the impact of papers produced by Vincent Castonguay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Castonguay. The network helps show where Vincent Castonguay may publish in the future.
Co-authorship network of co-authors of Vincent Castonguay
This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Castonguay. A scholar is included among the top collaborators of Vincent Castonguay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Castonguay. Vincent Castonguay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 1 | |
| 11 | First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826breakdown → | 100 |
| 12 | 2 | |
| 13 | 37 | |
| 14 | 5 | |
| 15 | 10 | |
| 16 | 6 | |
| 17 | 4 | |
| 18 | 4 | |
| 19 | 43 | |
| 20 | 39 |
About Vincent Castonguay
Vincent Castonguay is a scholar working on Obstetrics and Gynecology, Oncology and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (17 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Endometrial and Cervical Cancer Treatments (14 papers). The work is most often cited by research in Obstetrics and Gynecology (415 citations), Oncology (563 citations) and Reproductive Medicine (174 citations). Vincent Castonguay has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Vanessa Samouëlian, Ronnie Shapira‐Frommer, Pamela Salman, Mivael Olivera, Coraline Dubot, Kan Li, Krishnansu S. Tewari, Kosei Hasegawa, Bradley J. Monk and Domenica Lorusso. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.